If you have chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) or you are a caregiver of a patient with CLL or SLL, you can help by completing our surveys.
Lymphoma Canada and the CLL Patient Advocacy Group (CLLPAG) is preparing a submission for the pan-Canadian Oncology Drug Review (pCODR) for:
Venetoclax for the treatment of patients with relapsed chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).
The surveys provide us with the patient and caregiver input required for the submission. pCODR uses this information to help them make recommendations to the provinces and territories regarding funding for new cancer drugs.
You do not need to live in Canada to complete this survey.
BY COMPLETING THIS SURVEY, YOU ARE PART OF THE PROCESS THAT MAY HELP PATIENTS GAIN ACCESS TO THIS TREATMENT IN CANADA.
The survey will be open until midnight Pacific Time on Thursday, June 15th and should only take 10 minutes of your time.
You may access the survey by clicking the appropriate link below.
Please share and help us spread the word.
Thank you for your support.